Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability

Biological Psychiatry

Volumn 69, Issue 9, 2011, Pages 902-904

  Nandam, L Sanjay ^a,b   Hester, Robert ^c   Wagner, Joe ^a   Cummins, Tarrant D R ^a   Garner, Kelly ^a   Dean, Angela J ^a   Kim, Bung Nyun ^a,e   Nathan, Pradeep J ^d,f   Mattingley, Jason B ^a   Bellgrove, Mark A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e Seoul National University   (South Korea)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Atomoxetine; citalopram; methylphenidate; response inhibition; stop signal; variability

Indexed keywords

(1 BUTYLAMINO 3 METHYLBUTYL)(1 PYRROLIDINYL) KETONE; ATOMOXETINE; CITALOPRAM; GLUCOSE; METHYLPHENIDATE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; EXECUTIVE FUNCTION; HUMAN; MALE; MODULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPONSE INHIBITION; RESPONSE TIME; RIGHT HANDEDNESS; TASK PERFORMANCE; VELOCITY;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; CITALOPRAM; CROSS-OVER STUDIES; DOPAMINE UPTAKE INHIBITORS; DOUBLE-BLIND METHOD; HUMANS; INHIBITION (PSYCHOLOGY); MALE; METHYLPHENIDATE; NEUROPSYCHOLOGICAL TESTS; PROPYLAMINES; REACTION TIME; SEROTONIN UPTAKE INHIBITORS;

EID: 79954669582     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.11.014     Document Type: Article

References (20)

1. M.A. Bellgrove, C.D. Chambers, A. Vance, N. Hall, M. Karamitsios, and J.L. Bradshaw Lateralized deficit of response inhibition in early-onset schizophrenia Psychol Med 36 2006 495 505 (Pubitemid 43381002)
2. L. Menzies, S. Achard, S.R. Chamberlain, N. Fineberg, C.H. Chen, and N. del Campo Neurocognitive endophenotypes of obsessive-compulsive disorder Brain 130 2007 3223 3236 (Pubitemid 350209066)
3. M. Lijffijt, J.L. Kenemans, M.N. Verbaten, and H. van Engeland A meta-analytic review of stopping performance in attention-deficit/hyperactivity disorder: Deficient inhibitory motor control? J Abnorm Psychol 114 2005 216 222 (Pubitemid 40663762)
4. G.D. Logan, R.J. Schachar, and R. Tannock Impulsivity and inhibitory control Psychol Sci 8 1997 60 64
5. M.A. Bellgrove, R. Hester, and H. Garavan The functional neuroanatomical correlates of response variability: Evidence from a response inhibition task Neuropsychologia 42 2004 1910 1916 (Pubitemid 39223300)
6. K.A. Johnson, S.P. Kelly, M.A. Bellgrove, E. Barry, M. Cox, M. Gill, and I.H. Robertson Response variability in attention deficit hyperactivity disorder: Evidence for neuropsychological heterogeneity Neuropsychologia 45 2007 630 638 (Pubitemid 44958739)
7. S.R. Chamberlain, U. Muller, A.D. Blackwell, L. Clark, T.W. Robbins, and B.J. Sahakian Neurochemical modulation of response inhibition and probabilistic learning in humans Science 311 2006 861 863 (Pubitemid 43228852)
8. A. Bari, D.M. Eagle, A.C. Mar, E.S. Robinson, and T.W. Robbins Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats Psychopharmacology (Berl) 205 2009 273 283
9. S.R. Chamberlain, A. Hampshire, U. Muller, K. Rubia, N.D. Campo, and K. Craig Atomoxetine modulates right inferior frontal activation during inhibitory control: A pharmacological functional magnetic resonance imaging study Biol Psychiatry 65 2008 550 555
10. D.M. Eagle, A. Bari, and T.W. Robbins The neuropsychopharmacology of action inhibition: Cross-species translation of the stop-signal and go/no-go tasks Psychopharmacology (Berl) 199 2008 439 456
11. N.D. Volkow, G. Wang, J.S. Fowler, J. Logan, M. Gerasimov, and L. Maynard Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain J Neurosci 21 2001 RC121
12. C.W. Berridge, D.M. Devilbiss, M.E. Andrzejewski, A.F. Arnsten, A.E. Kelley, and B. Schmeichel Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function Biol Psychiatry 60 2006 1111 1120 (Pubitemid 44647216)
13. F.P. Bymaster, J.S. Katner, D.L. Nelson, S.K. Hemrick-Luecke, P.G. Threlkeld, and J.H. Heiligenstein Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit/hyperactivity disorder Neuropsychopharmacology 27 2002 699 711 (Pubitemid 35335888)
14. A.F. Arnsten, and A.G. Dudley Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in attention deficit hyperactivity disorder Behav Brain Funct 1 2005 2
15. A.R. Aron, and R.A. Poldrack Cortical and subcortical contributions to stop signal response inhibition: Role of the subthalamic nucleus J Neurosci 26 2006 2424 2433 (Pubitemid 44699002)
16. C.D. Chambers, H. Garavan, and M.A. Bellgrove Insights into the neural basis of response inhibition from cognitive and clinical neuroscience Neurosci Biobehav Rev 33 2009 631 646
17. C.J. Vaidya, S.A. Bunge, N.M. Dudukovic, C.A. Zalecki, G.R. Elliott, and J.D. Gabrieli Altered neural substrates of cognitive control in childhood ADHD: Evidence from functional magnetic resonance imaging Am J Psychiatry 162 2005 1605 1613 (Pubitemid 41318228)
18. J.W. Mink The basal ganglia: Focused selection and inhibition of competing motor programs Prog Neurobiol 50 1996 381 425 (Pubitemid 27028538)
19. J. Kuntsi, A.C. Wood, F. Rijsdijk, K.A. Johnson, P. Andreou, and B. Albrecht Separation of cognitive impairments in attention-deficit/hyperactivity disorder into 2 familial factors Arch Gen Psychiatry 67 2010 1159 1166
20. N. Ramoz, C. Boni, A.M. Downing, S.L. Close, S.L. Peters, and A.M. Prokop A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD) Neuropsychopharmacology 34 2009 2135 2142